CIK 0001517022
- Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208756903
- Phone
- +1 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award SVP, CFO and Treasurer acquired 200,000 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Open-market sale Director sold 4,567 shares at $0.36 ($1,653)
- 4 Grant or award SVP, Chief Medical Officer acquired 200,000 shares (grant or award)
- 4 Grant or award SVP, Chief Accounting Officer acquired 150,000 shares (grant or award)
- 4 Open-market sale CEO and President sold 79,026 shares at an average $2.17 ($171,143)
- 4 Open-market sale SVP, Chief Medical Officer sold 15,056 shares at an average $2.16 ($32,564)
- 4 Open-market sale SVP, Chief Accounting Officer sold 3,946 shares at $2.15 ($8,503)
- 4 Open-market sale SVP, Chief Operating Officer sold 21,533 shares at an average $2.17 ($46,637)
- 4 Open-market sale SVP, CCO sold 13,184 shares at an average $2.16 ($28,515)
- 4 Open-market sale SVP, Chief Legal Officer sold 21,062 shares at an average $2.17 ($45,615)
- 4 Open-market sale SVP, CFO and Treasurer sold 8,203 shares at an average $2.16 ($17,689)
- 4/A Other acquisition CEO and President acquired 1,248 shares (other)
- 4 Open-market sale SVP, Chief Accounting Officer sold 5,833 shares at $2.29 ($13,335)
Page 6 of 19 · 378 filings